Pregnancy Outcome After Exposure to Antidepressants and the Role of Maternal Depression
Authors:
- Marleen M. H. J. van GelderMGMarleen M. H. J. van Gelder
- Olav SpigsetOSOlav Spigset
- Gideon KorenGKGideon Koren
- Adrienne EinarsonAEAdrienne Einarson
- Malin Eberhard-GranMEMalin Eberhard-Gran
- 1 April 2012
- journal article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 32 (2) , 186-194
Abstract
Results of previous studies on the safety of antidepressants during pregnancy have been conflicting. The primary objective of this study was to investigate whether first-trimester exposure to antidepressants, specifically selective serotonin reuptake inhibitors (SSRIs), was associated with increased risk of congenital malformations. The secondary objective was to examine the effects of exposure to antidepressants during pregnancy on birth weight and gestational age. We included 63,395 women from the Norwegian Mother and Child Cohort Study. The women had completed 2 self-administered questionnaires at gestational weeks 17 and 30 on medication use and medical, sociodemographic, and psychological factors. Data on pregnancy outcome were retrieved from the Medical Birth Registry of Norway. Of the 63,395 women, 699 (1.1%) reported using antidepressants during pregnancy, most frequently SSRIs (0.9%). Exposure to SSRIs during the first trimester was not associated with increased risk of congenital malformations in general (adjusted odds ratio [OR], 1.22; 95% confidence interval [CI], 0.81–1.84) or cardiovascular malformations (adjusted OR, 1.51; 95% CI, 0.67–3.43). Exposure to antidepressants during pregnancy was not associated with increased risk of preterm birth (adjusted OR, 1.21; 95% CI, 0.87–1.69) or low birth weight (adjusted OR, 0.62; 95% CI, 0.33–1.16). This study does not suggest a strongly increased risk of malformations, preterm birth, or low birth weight following prenatal exposure to antidepressants. Without adjustments for level of maternal depression and various sociodemographic and lifestyle factors, antidepressant use during pregnancy would wrongly have been associated with an increased risk of preterm birth.Keywords
This publication has 14 references indexed in Scilit:
- Use of antidepressants during pregnancy and the risk of spontaneous abortionCanadian Medical Association Journal, 2010
- Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish dataPsychological Medicine, 2010
- Selective Serotonin Reuptake Inhibitor Exposure In Utero and Pregnancy OutcomesArchives of Pediatrics & Adolescent Medicine, 2009
- Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort studyBMJ, 2009
- Delivery Outcome in Relation to Maternal Use of Some Recently Introduced AntidepressantsJournal of Clinical Psychopharmacology, 2007
- Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studiesPharmacoepidemiology and Drug Safety, 2005
- Risks Associated With Selective Serotonin Reuptake Inhibitors in PregnancyObstetrics & Gynecology, 2005
- Outcomes of Prenatal Antidepressant ExposureAmerican Journal of Psychiatry, 2002
- The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 yearsActa Obstetricia et Gynecologica Scandinavica, 2000
- Delivery outcome after the use of antidepressants in early pregnancyEuropean Journal of Clinical Pharmacology, 1999